DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Cefotan (Cefotetan Disodium) - Side Effects and Adverse Reactions



In clinical studies, the following adverse effects were considered related to CEFOTAN therapy. Those appearing in italics have been reported during postmarketing experience.


Symptoms occurred in 1.5% of patients, the most frequent were diarrhea (1 in 80) and nausea (1 in 700); pseudomembranous colitis. Onset of pseudomembranous colitis symptoms may occur during or after antibiotic treatment or surgical prophylaxis. (See WARNINGS.)


Laboratory abnormalities occurred in 1.4% of patients and included eosinophilia (1 in 200), positive direct Coombs’ test (1 in 250), and thrombocytosis (1 in 300); agranulocytosis, hemolytic anemia, leukopenia, thrombocytopenia, and prolonged prothrombin time with or without bleeding.


Enzyme elevations occurred in 1.2% of patients and included a rise in ALT (SGPT) (1 in 150), AST (SGOT) (1 in 300), alkaline phosphatase (1 in 700), and LDH (1 in 700).


Reactions were reported in 1.2% of patients and included rash (1 in 150) and itching (1 in 700); anaphylactic reactions and urticaria.


Effects were reported in less than 1% of patients and included phlebitis at the site of injection (1 in 300), and discomfort (1 in 500).


Elevations in BUN and serum creatinine have been reported.


Nephrotoxicity has rarely been reported.


In addition to the adverse reactions listed above which have been observed in patients treated with cefotetan, the following adverse reactions and altered laboratory tests have been reported for cephalosporin-class antibiotics: pruritus, Stevens-Johnson syndrome, erythema multiforme, toxic epidermal necrolysis, vomiting, abdominal pain, colitis, superinfection, vaginitis including vaginal candidiasis, renal dysfunction, toxic nephropathy, hepatic dysfunction including cholestasis, aplastic anemia, hemorrhage, elevated bilirubin, pancytopenia, and neutropenia.

Several cephalosporins have been implicated in triggering seizures, particularly in patients with renal impairment, when the dosage was not reduced. (See DOSAGE AND ADMINISTRATION and OVERDOSAGE.) If seizures associated with drug therapy occur, the drug should be discontinued. Anticonvulsant therapy can be given if clinically indicated.


Below is a sample of reports where side effects / adverse reactions may be related to Cefotan. The information is not vetted and should not be considered as verified clinical evidence.

Possible Cefotan side effects / adverse reactions in 79 year old male

Reported by a pharmacist from United States on 2012-01-10

Patient: 79 year old male weighing 95.0 kg (209.0 pounds)

Reactions: Urticaria, Erythema, Rash Maculo-Papular, Respiratory Distress

Suspect drug(s):
    Dosage: 2 gm q12? iv
    Indication: Postoperative Care
    Start date: 2011-11-16
    End date: 2011-11-17

    Dosage: 2 gm q12? iv
    Indication: Prophylaxis
    Start date: 2011-11-16
    End date: 2011-11-17

See index of all Cefotan side effect reports >>

Drug label data at the top of this Page last updated: 2006-09-19

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017